Since it is proposed that AML stem cells originate from normal hematopoietic stem/progenitor cells (which collect mutations over time) at a stage when CD34 and CD123 were co-expressed [11], healthy CD34+CD123+ cells appear to be reasonable normal cell counterparts to CD34+CD123+ AML cells. Here, CD34 is linked to acute myeloid leukemia.